<code id='140B6D6EC2'></code><style id='140B6D6EC2'></style>
    • <acronym id='140B6D6EC2'></acronym>
      <center id='140B6D6EC2'><center id='140B6D6EC2'><tfoot id='140B6D6EC2'></tfoot></center><abbr id='140B6D6EC2'><dir id='140B6D6EC2'><tfoot id='140B6D6EC2'></tfoot><noframes id='140B6D6EC2'>

    • <optgroup id='140B6D6EC2'><strike id='140B6D6EC2'><sup id='140B6D6EC2'></sup></strike><code id='140B6D6EC2'></code></optgroup>
        1. <b id='140B6D6EC2'><label id='140B6D6EC2'><select id='140B6D6EC2'><dt id='140B6D6EC2'><span id='140B6D6EC2'></span></dt></select></label></b><u id='140B6D6EC2'></u>
          <i id='140B6D6EC2'><strike id='140B6D6EC2'><tt id='140B6D6EC2'><pre id='140B6D6EC2'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:71722
          Photo illustration of Stephen HEMSLEY -- UnitedHealth coverage from STAT
          Stephen Hemsley, chair of the board and former chief executive officer of UnitedHealth Group Inc. Photo illustration: Alex Hogan; Source: AP

          Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns an investment firm that manages his own portfolio of UnitedHealth stock and oversees other wealthy individuals’ accounts that have held shares of companies that have direct business with or indirect ties to United.

          It’s an unusual arrangement for someone in such a prominent role at one of the largest health care corporations in the world, according to several experts in securities and corporate law interviewed by STAT, and one that they said highlights shortcomings in government disclosure requirements and raises concerns about potential conflicts of interest.

          advertisement

          The arrangement is perfectly legal. But while other board chairs at large publicly traded health care companies, like Thomas Frist III at HCA Healthcare, hold high-ranking titles in the investment world, none were longtime chief executives of the same company they chair, like Hemsley. UnitedHealth also does not disclose Hemsley’s investment firm ownership to its shareholders in regular disclosures.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Medicare innovation center doesn’t save money, experts say
          Medicare innovation center doesn’t save money, experts say

          AdobeWASHINGTON—AkeyObama-erainitiativewassupposedtosaveMedicaremoneybytestingnewpoliciesforcuttingh

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          RSV injection headlines need to be accurate for good uptake

          STAT/AstraZenecaviaAPAstheoristsfromSamuelColeridgetoKennethBurkehavenoted,languageoftendoesourthink